Glimisave MV 1 Tablet SR

By Glimisave MV

Rx

15 Tablet SR in a Strip

Composition icon

Composition

Glimepiride(1mg) + Metformin(500mg) + Voglibose(0.2mg)

Manufacturer - Eris Lifesciences Ltd icon

Manufacturer - Eris Lifesciences Ltd

8th Floor, Commerce House IV, Prahladnagar, Ahmedabad – 380015 Gujarat, India

Expires on or after icon

Expires on or after

April, 2026

About Glimisave MV 1 Tablet SR

"Glimisave MV 1 Tablet SR is a medicine used for treating type 2 diabetes in adults. It is a combination of Glimepiride, Metformin, and Voglibose which are all antidiabetic agents. This medication helps to manage blood sugar levels when diet, exercise, and other treatments are not enough to control diabetes effectively.

It is important to take Glimisave MV 1 Tablet SR with food regularly at the same time each day as prescribed by your doctor. Your doctor will determine the appropriate dosage for you based on how well the medicine is working for you. It is crucial to keep taking the medication even if you feel well or your blood sugar levels are under control to prevent complications such as kidney damage, blindness, nerve issues, or limb loss.

When taking Glimisave MV 1 Tablet SR, be aware of the potential side effects which may include low blood sugar levels (hypoglycemia). Symptoms of low blood sugar can include sweating, dizziness, headache, and shaking. It is important to recognize these signs and know how to address them, such as having a source of glucose on hand. Avoiding alcohol consumption is also recommended to prevent low blood sugar levels.

While taking Glimisave MV 1 Tablet SR, some individuals may experience side effects like taste changes, nausea, diarrhea, stomach pain, headache, swelling, blurred vision, bone fractures, and respiratory infections. Weight gain may also occur in some people. This medication is not suitable for individuals with type 1 diabetes mellitus, diabetic ketoacidosis, severe kidney or liver disease, or heart conditions. Pregnant or breastfeeding women should consult their doctor before taking this medicine.

Regular monitoring of blood sugar levels and periodic blood tests may be necessary while taking Glimisave MV 1 Tablet SR. It is important to follow your doctor's advice and maintain a healthy lifestyle with proper diet, regular exercise, and weight management as part of your diabetes treatment plan."


Benefits

Glimisave MV 1 Tablet SR offers several benefits in the treatment of Type 2 diabetes mellitus. This medication plays a crucial role in controlling high blood glucose levels, which is essential in managing diabetes effectively. By slowing down the breakdown of food in the intestine to simple glucose,Glimisave MV 1 Tablet SR helps to decrease the sudden spikes in blood sugar levels after meals. Additionally, it facilitates the elimination of excess glucose from the body through urine.


Maintaining optimal blood glucose levels is vital as it significantly lowers the risk of developing serious complications associated with diabetes, such as kidney damage, eye damage, nerve problems, and the potential loss of limbs. Moreover, individuals with Type 2 diabetes who also have cardiovascular disease can benefit from Glimisave MV 1 Tablet SR as it reduces the risk of mortality from heart-related issues.


By incorporating Glimisave MV 1 Tablet SR into your daily routine alongside a balanced diet and regular exercise, you can lead a normal and healthy life. It is important to adhere to the prescribed regimen consistently to ensure continuous protection of your future health. This medication is a valuable tool in the management of Type 2 diabetes, offering not only immediate benefits in controlling blood sugar levels but also long-term advantages in preventing severe complications and enhancing overall well-being.


How to use the Glimisave MV 1 Tablet SR

To use Glimisave MV 1 Tablet SR, follow your doctor's instructions on dosage and duration. Swallow the tablet whole without chewing, crushing, or breaking it. It is important to take Glimisave MV 1 Tablet SR on an empty stomach. Make sure to adhere to the prescribed dose and duration provided by your doctor for the best results. If you have any questions or concerns about using this medication, consult your healthcare provider for guidance.


Uses of Glimisave MV 1 Tablet SR

Glimisave MV 1 Tablet SR is mainly used for managing Type 2 diabetes mellitus. This medication helps in controlling blood sugar levels in individuals with this condition. It is prescribed by healthcare professionals to help patients maintain healthy blood sugar levels. By following the recommended dosage, Glimisave MV 1 Tablet SR can be effective in the treatment of Type 2 diabetes mellitus.


What conditions Glimisave MV 1 Tablet SR treats?

Glimisave MV 1 Tablet SR is a medication used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes by slowing down the breakdown of food into glucose, reducing the rise in blood sugar levels after meals, and eliminating excess glucose through urine. Managing blood glucose levels is crucial in preventing serious complications of diabetes such as kidney damage, eye problems, nerve issues, and limb loss. Regular use, along with a healthy diet and exercise, can help individuals with diabetes lead a normal and healthy life.


Should you consult a doctor?

Seek medical attention immediately if you experience persistent and severe side effects such as hypoglycemia, which can lead to symptoms like sweating, dizziness, headache, and shaking. Consult your doctor if you have concerns about common side effects like nausea, diarrhea, abdominal pain, or loss of appetite. Additionally, if you have type 1 diabetes, diabetic ketoacidosis, severe kidney or liver disease, or a history of heart disease, do not take Glimisave MV 1 Tablet SR without consulting your doctor first. Pregnant or breastfeeding women should also seek medical advice before starting this medication. Regular monitoring of blood sugar levels and potential side effects is essential, so keep in touch with your healthcare provider and follow their guidance closely. Any unusual symptoms or changes in your health should be reported to your doctor promptly for proper evaluation and management.


Side effects of Glimisave MV 1 Tablet SR

When taking Glimisave MV 1 Tablet SR, some common side effects may occur. These side effects are generally mild and may go away as your body gets used to the medication. However, if these side effects persist or if you are concerned about them, it is important to consult your doctor. Common side effects of Glimisave MV 1 Tablet SR include nausea, diarrhea, abdominal pain, hypoglycemia (low blood glucose level), and loss of appetite. If you experience any of these side effects and they are bothersome or persistent, seek medical advice to address your concerns. It is essential to monitor and communicate any side effects with your healthcare provider for appropriate guidance and support.


Safety advice

scroll

liver

Glimisave MV 1 Tablet SR should be used carefully in individuals with liver issues. It may be necessary to adjust the dosage of Glimisave MV 1 Tablet SR in such cases. It is advised to seek guidance from your healthcare provider before using this medication. Typically, Glimisave MV 1 Tablet SR is initiated at a low dose for patients with mild to moderate liver problems. However, it is not recommended for use in individuals with severe liver disease.

scroll

kidney

Glimisave MV 1 Tablet SR may not be safe for patients with kidney disease and is not recommended for those with severe kidney issues. Consult your doctor before use.

scroll

alcohol

It is unsafe to consume alcohol with Glimisave MV 1 Tablet SR. Avoid alcohol when taking this medication. Caution - Pregnancy It is important to consult your doctor regarding alcohol consumption with Glimisave MV 1 Tablet SR during pregnancy.

scroll

driving

To ensure safety, avoid driving if experiencing low or high blood sugar symptoms while taking Glimisave MV 1 Tablet SR.

scroll

pregnancy

Glimisave MV 1 Tablet SR may be harmful during pregnancy based on animal studies. Consult your doctor to assess potential risks and benefits before using it.

scroll

breastfeeding

Glimisave MV 1 Tablet SR is likely unsafe during breastfeeding. Limited data indicates it may pass into breastmilk and harm the baby.


Consumption warning before consuming Glimisave MV 1 Tablet SR

Before consuming Glimisave MV 1 Tablet SR, it's essential to note several crucial points. Firstly, always take this medication with food and at the same time daily for optimal results. Your doctor will determine the appropriate dosage based on your blood sugar levels, which may require adjustments over time. Even if you feel fine or your blood sugar is under control, continue taking the medicine as stopping abruptly could lead to elevated blood sugar levels, posing risks such as kidney damage, blindness, nerve issues, or limb loss.


Remember, Glimisave MV 1 Tablet SR may cause low blood sugar levels (hypoglycemia) as a common side effect. Be attentive to symptoms like sweating, dizziness, headache, or shaking and have fast-acting glucose sources on hand. Moreover, avoid alcohol consumption as it can escalate the risk of low blood sugar. Additional side effects might include taste changes, nausea, diarrhea, or blurred vision. Notably, this medication is not suitable for individuals with type 1 diabetes, diabetic ketoacidosis, severe kidney or liver disease, or a history of heart problems. If pregnant or breastfeeding, consult a healthcare provider before using Glimisave MV 1 Tablet SR. Regular monitoring of blood sugar levels is vital, along with periodic blood tests to assess blood cell counts and liver function.


What if you forgot to take Glimisave MV 1 Tablet SR?

If you forget to take your Glimisave MV 1 Tablet SR, try to take it as soon as you remember. But if it's nearly time for your next dose, just skip the missed one and stick to your usual dosage routine. Remember not to double up on doses to make up for the one you missed.


Related lab tests

For patients taking Glimisave MV 1 Tablet SR, related lab tests may include Glucose - Fasting Blood, Glucose - Postprandial Blood, and Glycosylated Hemoglobin. These tests are important to monitor blood sugar levels and the overall effectiveness of the medication in managing diabetes. Glucose - Fasting Blood test measures the sugar levels in the blood after fasting for a certain period of time, providing insights into how the body processes glucose without food intake. The Glucose - Postprandial Blood test, on the other hand, measures blood sugar levels after a meal, indicating how the body handles glucose after eating. Lastly, the Glycosylated Hemoglobin test, also known as HbA1c test, gives an average of blood sugar levels over the past 2-3 months, offering a long-term view of blood sugar control. Regular monitoring of these lab tests can help healthcare providers tailor treatment plans for individuals taking Glimisave MV 1 Tablet SR to better manage their diabetes.


Additional Information

Habit FormingNo
Chemical Class-
Therapeutic ClassANTI DIABETIC
Action Class-

FAQs


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

245.32

Inclusive of all taxes

Content verified by

chevron-right

Dr. Upasana Bhatia

MBBS - General Medicine

Last update on 01-Oct-2024